Article: German Biofrontera completes capital increase.

(ADPnews) - Sep 10, 2009 - German biotechnology firm Biofrontera AG (ETR:B8F) has successfully completed a capital increase, which it initiated as part of the restructuring of its 8% convertible bond 2005/2010.

A total of 1.2 million shares were subscribed to at a share price of EUR 1.50 (USD 2.19), the company said yesterday.

With the capital hike and considering the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!